Products and Services
COREALIS Formulation & Process Development
Source:
Ropack, Inc.
Formulation & Process Development by COREALIS Pharma, Inc.
Proof of Concept
- Feasibility study for the development of a solid dosage form of an active ingredient
Pre-Formulation
- Compatibility study of the excipients with the active ingredient
- Characterization of the active ingredient using analytical techniques such as SEM, XRPD, DSC, TGA, NMR, HPLC, and LC-MS, as well as physical testing methodologies such as the determination of particle size, distribution, compressibility, flow, and stability; in order to provide practical insights and quickly optimize the formulation.
Formulation Development
- Tablets, capsules, and granules
- New chemical entities, biotechnology products, and controlled substances
- Immediate or modified release dosage forms
- Gastric protection
- Sublingual (orally dissolving tablets)
- Effervescent
- Delayed or sustained release
- Formulation for patent approval
- Evaluation of formulations
- Content and weight uniformity
- Dissolution testing
- Permeability studies (PAMPA and Caco-2)
- Stability studies
- In-vitro bioequivalence studies
- Flow testing
- Compression testing
- Hardness testing
- Disintegration testing
- Friability testing
- Bulk and tap density testing
Process Development
- Development of the manufacturing process of the product: direct compression, dry or wet granulation, encapsulation, and coating
- Determination of the critical manufacturing steps and parameters
- Establishment and justification of the finished product specifications
- Process implementation justification of the tests and specifications to be respected during production

